Company Profile

METROPOLIS HEALTHCARE LTD.

NSE : METROPOLISBSE : 542650ISIN CODE : INE112L01020Industry : Hospital & Healthcare ServicesHouse : Metropolis
BSE1957.90-21 (-1.06 % )
PREV CLOSE (Rs.) 1978.90
OPEN PRICE (Rs.) 1941.00
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 2062
TODAY'S LOW / HIGH (Rs.)1941.00 1999.25
52 WK LOW / HIGH (Rs.)993.2 2321
NSE1959.30 -20.05 (-1.01 % )
PREV CLOSE(Rs.) 1979.35
OPEN PRICE (Rs.) 1984.95
BID PRICE (QTY) 1959.30 (110 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 40154
TODAY'S LOW / HIGH(Rs.) 1952.00 1999.00
52 WK LOW / HIGH (Rs.)998.05 2323

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 0.00
Dividend Yield(%) 0.41
TTM EPS (Rs.) 26.02
P/E Ratio 75.24
Book Value (Rs.) 115.55
Face Value (Rs.) 2
MCap (Rs. in Mn) 100081.61
Price/Earning (TTM) 60.11
Price/Sales (TTM) 13.51
Price/Book (MRQ) 16.94
PAT Margin (%) 16.84
ROCE (%) 31.74
Incorporation Year : 2000

Management Info :

Sushil Kanubhai Shah - Chairman Ameera Sushil Shah - Managing Director

Registered Office :

Address : 250 D Udyog Bhavan,Hind Cycle Marg,Worli,
Mumbai,
Maharashtra-400030

Phone : 022 6258 2810

Registrar's Details : Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS More
20Feb02-20-2021$Metropolis Healthcare submits voting results for postal ballot Metropolis Healthcare submit

Pursuant to Regulation 30 and 44(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Metropolis Healthcare has informed that the following resolutions have been passed by the members of the Company by requisite majority on February 18, 2021, being the last date for remote E-voting: Approval for increase in limit to provide loan, guarantee or security in respect of loan to any person or Body Corporate or to make investment in any other Body Corporate; and to issue, offer and allot equity shares on a Preferential Basis. In this regard, the company has submitted the details of the Voting results as ‘Annexure A’ and the Scrutinizer’s report dated February 19, 2021 received by the Company on February 20, 2021 as ‘Annexure B’ for the Postal Ballot process conducted by the Company. The Voting results and the Scrutinizer’s report for the Postal Ballot process will also be made available on the website of the Company at www.metropolisindia.com and website of NSDL at www.evoting.nsdl.com.

The above information is a part of company’s filings submitted to BSE.

Pursuant to Regulation 30 and 44(3) of the Securities and Excha..
04Feb02-04-2021$ Board Meeting Intimation for Intimation Of Notice Of Board Meeting To Be Held On Wednesday, February 10, 2021 Board Meeting Intimation fo
Metropolis Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2021 ,inter alia, to consider and approve This is to inform you that a meeting of the Board of Directors of the Company ('the Board') is scheduled to be held on Wednesday, February 10, 2021 through Video Conferencing to inter-alia: i. Consider and approve the Unaudited Standalone & Consolidated Financial Results of the Company for the Quarter ended December 31, 2020. ii. Consider the proposal for declaration of an Interim Dividend for the Financial Year 2020-2021. The Record date for the purpose of determining shareholders eligible for Interim dividend, if any, declared by the Board shall be Friday, February 19, 2021.
Metropolis Healthcare Ltdhas informed BSE that the meeting of t..
20Jan01-20-2021$ Notice Of Postal Ballot Notice Of Postal Ballot
Dear Sir/Madam, Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, and our earlier intimation having reference no. MHL/Sec&Legal/2020-21/161 dated January 17, 2021, wherein we had informed that the Board of Directors had approved the Postal ballot Notice and authorized the Company officials to finalize and issue the same on behalf of the Board. In this regard, we herein enclose the Postal Ballot Notice seeking the approval of the members of the Company for the matters mentioned therein. We wish to further inform you that the Postal Ballot Notice has been sent to the shareholders of the Company today via email in compliance with the relevant Circulars issued by the Ministry of Corporate Affairs and the Securities and Exchange Board of India. This is for your information and records.
Dear Sir/Madam, Pursuant to Regulation 30 of the Securities..
18Jan01-18-2021$Metropolis Healthcare gets nod to acquire Hitech Metropolis Healthcare gets n

Metropolis Healthcare has received approval for acquisition of entire 100% stake in Dr. Ganesan’s Hitech Diagnostic Centre and its subsidiary (Hitech) from its existing promoters and shareholders. The consideration will be discharged partly by cash and partly by issuance of equity shares of the company. The board of director of the company in their meeting held on January 17, 2021 has approved the same.

Metropolis Healthcare offers a comprehensive range of clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.

Metropolis Healthcare has received approval for acquisition of..
18Jan01-18-2021$ Announcement under Regulation 30 (LODR)-Press Release / Media Release Announcement under Regulati
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you about the Press Release on the topic: ''Metropolis Healthcare to acquire Hitech Diagnostic Centre to strengthen its leadership position in South India'
Pursuant to Regulation 30 of the Securities and Exchange Board..
Financials More
Rs. in Millions
QTR Dec 20 ANNUAL 20
Net Profit486.961120.53
Gross Profit 644.88 1399.9
Operating Profit 743.722019.22
Net Sales 2244.276653.07
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Fortis MalarHospital (BSE)
 52.75 (1.25%)
M.Cap ( in Cr)
98.86
Medinova Diagnostic (BSE)
 23.75 (2.59%)
M.Cap ( in Cr)
23.71
Choksi Lab (BSE)
 9.48 (4.98%)
M.Cap ( in Cr)
6.60
Tejnaksh Healthcare (BSE)
 70.60 (0.57%)
M.Cap ( in Cr)
71.71
Dr Lalchandani Labs (BSE)
 11.00 (0.00%)
M.Cap ( in Cr)
4.77
Shareholding Pattern More
NON-INSTITUTION 7.78 %
PROMOTERS 50.39 %
MUTUAL FUNDS/UTI 12.75 %
FI/BANKS/INSURANCE 1.51 %
GOVERNMENT 0 %
FII 0 %
F & O Quotes